F255-0033 Screening compound: N-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}cyclohexanecarboxamide

F255-0033 Screening compound: N-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}cyclohexanecarboxamide
F255-0033 Screening compound: N-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}cyclohexanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F255-0033
N-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}cyclohexanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F255-0033

Molecular Formula

C28H29N3O (C28 H29 N3 O)

Compound Name

N-{4-[2-(1-phenyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}cyclohexanecarboxamide

IUPAC name

N-{4-[2-(1-phenyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}cyclohexanecarboxamide

SMILES

O=C(C1CCCCC1)Nc1ccc(CCc2nc(cccc3)c3n2-c2ccccc2)cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

423.56

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.194

Distribution Coefficient, logD

6.143

Water Solubility, LogSw

-5.79

Polar Surface Area

34.898

Acid Dissociation Constant (pKa)

11.95

Base Dissociation Constant (pKb)

6.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

F255-0033 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GABA Library (7115 compounds)

PI3K-Targeted Library (17255 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with F255-0033 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F255-0033?
Check Price and Availability of F255-0033, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F255-0033 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F255-0033
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F255-0033
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F255-0033 available by request